Literature DB >> 3971380

Differential characteristics of two newly established human breast carcinoma cell lines.

M Y Chu, M G Hagerty, M C Wiemann, L M Tibbetts, S Sato, F J Cummings, H A Bogaars, E H Leduc, P Calabresi.   

Abstract

Two human breast carcinoma cell lines, EP and MW, were established in culture from malignant pleural effusions. In addition to producing tumors in antithymocyte serum-immunosuppressed mice, both cell lines showed epithelial characteristics and anchorage-independent growth in soft agar. EP and MW differed in morphology (spindle-shaped versus round), chromosomal mode (hyperdiploid versus near triploid), estrogen receptor content (43.8 versus 5.1 fmol/mg protein), cloning efficiency (0.24 versus 15%), and activities (milliunits/10(6) cells) of creatine phosphokinase (25.7 versus 62.6) and lactate dehydrogenase (346.7 versus 778.5). Electron microscopy revealed that MW cells had more perinuclear filamentous material and more frequent intracytoplasmic vacuole formation than did EP cells. While having no effect on MW cells at the concentrations studied (10(-5) to 10(-11) M), beta-estradiol (10(-7) M) stimulated the growth of EP cells by 106% over the hormone-depleted control. In a variety of systems, EP was consistently the more drug sensitive of the two lines. In vitro, EP was significantly (p less than 0.001) more sensitive to methotrexate, vincristine, and 5-fluorouracil, respectively. In antithymocyte serum-mouse xenografts, EP displayed a greater response to three different dosages of a combination of cyclophosphamide, methotrexate, and 5-fluorouracil. One such dosage (cyclophosphamide, 32.0 mg/kg/day; methotrexate, 13.0 mg/kg/day; 5-fluorouracil, 190.0 mg/kg/day; for 1 day) reduced EP and MW tumor weights to 5.9 and 41% of controls, respectively. These results correlated well with the clinical responses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3971380

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  New cell lines of human breast cancer origin.

Authors:  G Calaf; J Abarca-Quinones; F Feuilhade; J Beaune; G Dupre; M Orrico; N Barnabas-Sohi; J C Kouyoumdjian
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Mutations in p53 as potential molecular markers for human breast cancer.

Authors:  I B Runnebaum; M Nagarajan; M Bowman; D Soto; S Sukumar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma.

Authors:  J Gioanni; D Le François; E Zanghellini; C Mazeau; F Ettore; J C Lambert; M Schneider; B Dutrillaux
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

4.  Development of a new metastatic human breast carcinoma xenograft line.

Authors:  R R Mehta; J M Graves; A Shilkaitis; T K Das Gupta
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.